Q1 2026 Management View Kim Kelderman, CEO, President & Director, reported that organic revenue declined 1% in Q1, ...
About 1 million people in the U.S. live with multiple sclerosis, a chronic autoimmune disease that inflames the nervous ...
To make the therapy safer and more adaptable, UChicago researchers developed a new “split” system called GA1CAR. This uses ...
T cell therapies have revolutionized cancer treatment—but so far, their success has been largely limited to blood cancers.
A single infusion of CRISPR Therapeutics' experimental gene therapy was safe and reduced levels of harmful LDL cholesterol ...
CD19 chimeric antigen receptor T-cell therapy improved lung function and skin thickness in patients with severe refractory systemic sclerosis, with 96% remaining off SSc treatment during follow-up, ...
Only a few dozen patients with lupus have been treated with CAR-T-cell therapy — but in a small German study, all five ...
Community-based CAR T-cell therapy improves access, reducing travel burdens and hospital admissions for patients with blood ...
Patients with uveal melanoma may respond to T-cell therapy directed at an antigen that is highly expressed in the tumors, ...
Lifileucel shows a 25.6% objective response rate and 71.8% disease control rate in advanced nonsquamous NSCLC patients, ...
Dr. Christina Cho highlights the Adult Stem Cell Transplant and Cellular Therapy Program for its innovative research and compassionate, multidisciplinary team. Dr ...
The global car t-cell therapy market size is predicted to increase from USD 7.64 billion in 2025 and is anticipated to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback